Respiratory syncytial virus (RSV)
Respiratory syncytial virus (RSV) is a contagious respiratory virus that usually causes mild, cold-like symptoms. RSV is common around the world and is most active in Canada during the fall and winter months (when people in Canada are most likely to catch RSV and become sick). Symptoms of RSV are usually similar to that of the common cold, and for most people, the illness itself is generally mild.
RSV enters your body through your mouth, eyes, and nose through infected droplets. It is spread through close contact with others (e.g., someone who is infected coughs or sneezes next to you, or through sharing personal items such as drinks), and by touching contaminated surfaces (e.g., touching a countertop that an infected person recently touched or sneezed next to).
Symptoms typically appear two to eight days after someone has been exposed to RSV and can include coughing, runny nose, sneezing, wheezing, fever, and a decrease in appetite and energy.
Check out our resources on respiratory syncytial virus (RSV) immunization and share with your network!
Factsheets and Program Chart
Products available in Canada to protect against respiratory syncytial virus (RSV)
(program chart – PDF: 420 KB)
Patient Videos
Protecting infants from RSV
Preventing RSV: what you need to know
Eitan’s story
Videos for healthcare professionals
Videos for parents and caregivers
Posters
Social media images
Is there a vaccine that protects against respiratory syncytial virus (RSV)?
(image for Twitter – .png: 1.6 MB)
Is there a vaccine that protects against respiratory syncytial virus (RSV)?
(image for Facebook – .png: 976 KB)
NACI Statements
- Statement on the prevention of respiratory syncytial virus disease in older adults. 12 July 2024. National Advisory Committee on Immunization (NACI).
- Summary of NACI statement of July 12, 2024: Statement on the prevention of respiratory syncytial virus disease in older adults. 12 July 2024. National Advisory Committee on Immunization (NACI).
- Canadian Immunization Guide: Respiratory syncytial virus (RSV) vaccines. Updated August 2024. Public Health Agency of Canada (PHAC).
- Statement on the prevention of respiratory syncytial virus (RSV) disease in infants. 17 May 2024. National Advisory Committee on Immunization (NACI).
- Summary of the NACI Statement on the prevention of respiratory syncytial virus (RSV) disease in infants. 17 May 2024. National Advisory Committee on Immunization (NACI).
- Statement on the prevention of respiratory syncytial virus (RSV) disease in infants: Supplementary systematic review of economic evidence. 17 May 2024. National Advisory Committee on Immunization (NACI).
- Respiratory syncytial virus (RSV): Canadian Immunization Guide. Public Health Agency of Canada. Updated 21 June 2024.
- Respiratory syncytial virus (RSV): Prevention and risks. Public Health Agency of Canada. May 2024.